Genfit S.A. (GNFTF)
USD 5.55
(0.0%)
USD 5.55
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -26.58 Million EUR | 24.79% |
| 2022 | -35.33 Million USD | -214.28% |
| 2021 | 30.92 Million USD | 129.05% |
| 2020 | -106.44 Million USD | -58.57% |
| 2019 | -67.12 Million USD | 23.65% |
| 2018 | -87.92 Million USD | -15.44% |
| 2017 | -76.15 Million USD | -80.16% |
| 2016 | -42.27 Million USD | -80.91% |
| 2015 | -23.36 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 FY | -26.58 Million EUR | 24.79% |
| 2023 Q2 | -23.74 Million USD | -119.4% |
| 2023 Q1 | -10.82 Million EUR | 34.86% |
| 2023 Q3 | 2.81 Million EUR | 111.87% |
| 2023 Q4 | 14.26 Million EUR | 406.21% |
| 2022 Q4 | -16.61 Million USD | -412.85% |
| 2022 Q3 | 5.31 Million EUR | 130.35% |
| 2022 Q2 | -17.49 Million USD | 0.0% |
| 2022 FY | -35.33 Million USD | -214.28% |
| 2021 Q2 | -37.32 Million USD | 0.0% |
| 2021 FY | 30.92 Million USD | 129.05% |
| 2021 Q4 | 66.7 Million USD | 0.0% |
| 2020 Q2 | -61.19 Million USD | 0.0% |
| 2020 FY | -106.44 Million USD | -58.57% |
| 2020 Q4 | -39.19 Million USD | 0.0% |
| 2019 FY | -67.12 Million USD | 23.65% |
| 2019 Q2 | -58.42 Million USD | 0.0% |
| 2019 Q4 | -11.49 Million USD | 0.0% |
| 2018 FY | -87.92 Million USD | -15.44% |
| 2017 FY | -76.15 Million USD | -80.16% |
| 2016 FY | -42.27 Million USD | -80.91% |
| 2015 FY | -23.36 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | 62.973% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 640.814% |
| SQZ Biotechnologies Company | -75.82 Million USD | 64.946% |
| Evofem Biosciences, Inc. | -17.84 Million USD | -48.933% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 132.473% |
| Mesoblast Limited | -84.14 Million USD | 68.412% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -1630.414% |
| Genus plc | 6.4 Million USD | 515.313% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 372.826% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | -2753.83% |
| Marizyme, Inc. | -34.08 Million USD | 22.022% |
| ContraFect Corporation | -56.88 Million USD | 53.277% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | -218.323% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | -483.57% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -1795.875% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | -832.466% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | -866.251% |
| MultiCell Technologies, Inc. | -722.81 USD | -3677214.924% |
| Accustem Sciences Inc. | -3.74 Million USD | -609.478% |
| RVL Pharmaceuticals plc | -58.99 Million USD | 54.942% |
| EV Biologics, Inc. | -483.06 Thousand USD | -5402.399% |
| Q BioMed Inc. | -3.44 Million USD | -671.415% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 850.847% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -6722.907% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | -911.6% |
| Biomind Labs Inc. | -1 Million USD | -2532.718% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | -4.87 Million USD | -444.723% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | -299.819% |
| Skye Bioscience, Inc. | -13.67 Million USD | -94.415% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | -1238.046% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -88641.987% |
| Arch Therapeutics, Inc. | -5.04 Million USD | -426.912% |
| IMV Inc. | -38.67 Million USD | 31.267% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | -67.489% |
| Curative Biotechnology, Inc. | -1.93 Million USD | -1275.342% |
| GB Sciences, Inc. | -1.42 Million USD | -1771.16% |
| Alpha Cognition Inc. | -9.7 Million USD | -173.862% |
| HST Global, Inc. | -140.9 Thousand USD | -18763.506% |
| CSL Limited | 3.7 Billion USD | 100.718% |
| Halberd Corporation | -75.05 Thousand USD | -35316.389% |
| Enzolytics Inc. | -2.14 Million USD | -1136.969% |
| Resverlogix Corp. | -12.74 Million USD | -108.487% |
| Affymax, Inc. | -15.04 Million USD | -76.658% |
| SYBLEU INC | -149.18 Thousand USD | -17717.402% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | -738.943% |
| argenx SE | -425.04 Million USD | 93.747% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | 52.115% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | -2445.977% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | -1582.966% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | -680.622% |
| AVAX Technologies, Inc. | 6.69 Million USD | 497.138% |
| Zenith Capital Corp. | -8.94 Million USD | -197.216% |
| Genscript Biotech Corporation | -415.79 Million USD | 93.607% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -152474.479% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | -982.549% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -15397.68% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | 51.648% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | -816.157% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | -2601.074% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | -1325.683% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.25 Million USD | -2016.242% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -1225.846% |
| BioStem Technologies, Inc. | -7.77 Million USD | -241.691% |
| ONE Bio Corp. | 13.68 Million USD | 294.276% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -14545.838% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -1890.369% |
| Wesana Health Holdings Inc. | -1.12 Million USD | -2262.864% |
| Agentix Corp. | -1.37 Million USD | -1837.662% |
| LadRx Corporation | -3.82 Million USD | -595.152% |
| Cell Source, Inc. | -4.32 Million USD | -514.517% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -6297.435% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -3769.277% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -3769.277% |
| NovAccess Global Inc. | -2.46 Million USD | -977.527% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | -810.447% |
| Itoco Inc. | -919.14 Thousand USD | -2791.834% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | -527.121% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -2275.335% |
| Kadimastem Ltd | -3.04 Million USD | -774.27% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -10055.659% |
| CytoDyn Inc. | -18.05 Million USD | -47.192% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -105501.907% |
| Mobile Lads Corp. | -554.55 Thousand USD | -4693.075% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -11977.536% |
| Qrons Inc. | -643.67 Thousand USD | -4029.4% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -4606.732% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.22 Million USD | -1091.993% |
| Rebus Holdings, Inc. | -664 Thousand USD | -3903.012% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | -1363.399% |
| International Stem Cell Corporation | -663 Thousand USD | -3909.05% |
| Bioxytran, Inc. | -3.82 Million USD | -595.785% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -50393.921% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -130578.466% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | 26.708% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | -1542.769% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -3512.223% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | -754.388% |
| Neutra Corp. | -229.48 Thousand USD | -11482.406% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -51.548% |
| PureTech Health plc | -146.19 Million USD | 81.819% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | -23.679% |
| IXICO plc | -1.43 Million USD | -1749.687% |
| IntelGenx Technologies Corp. | -9.49 Million USD | -180.055% |
| Gelesis Holdings, Inc. | -121.8 Million USD | 78.178% |
| CSL Limited | 3.81 Billion USD | 100.697% |
| Cellectis S.A. | -108.85 Million USD | 75.583% |